Welcome to our dedicated page for Agilent Technologies news (Ticker: A), a resource for investors and traders seeking the latest updates and insights on Agilent Technologies stock.
Agilent Technologies Inc (A) delivers cutting-edge analytical instruments and laboratory solutions for scientific advancement across biopharmaceutical, diagnostic, and environmental sectors. This page provides investors and industry professionals with a centralized source for all official company announcements and market-relevant developments.
Access real-time updates on Agilent's financial performance, strategic partnerships, product innovations, and regulatory milestones. Our curated news collection includes earnings releases, executive leadership updates, R&D breakthroughs, and industry event coverage—all essential for tracking the company's impact on life sciences and laboratory technology.
Key focus areas include advancements in genomic research tools, sustainability initiatives in lab operations, and cross-sector collaborations driving scientific discovery. Bookmark this page to stay informed about Agilent's evolving role in enabling precision medicine, environmental testing, and next-generation materials analysis.
Agilent Technologies Inc. (NYSE: A) reported second-quarter revenue of $1.525 billion, marking a 23% increase year-over-year and 19% growth on a core basis. GAAP net income rose to $216 million or 70 cents per share from $101 million or 32 cents a year prior. Non-GAAP net income reached $299 million or 97 cents per share, compared to $223 million or 71 cents last year. The company raised its fiscal 2021 revenue outlook to between $6.15 billion and $6.21 billion, with non-GAAP earnings guidance adjusted to $4.09 to $4.14 per share.
Agilent Technologies (NYSE: A) is set to participate in the Jefferies Virtual Healthcare Conference on June 1, 2021, at 2:00 p.m. (ET). Bob McMahon, Agilent's Chief Financial Officer, will represent the company during this event. Interested participants can access the webcast through the Investor Relations section of the Agilent website.
Agilent Technologies, Inc. (NYSE: A) has declared a quarterly dividend of 19.4 cents per share, payable on July 28, 2021, to shareholders on record as of July 6, 2021. The company's future dividend amounts are subject to approval by its board of directors. In fiscal year 2020, Agilent generated $5.34 billion in revenue and employs 16,400 people globally. The press release highlights the company's commitment to returning value to shareholders while noting potential risks associated with forward-looking statements regarding its dividend program.
Agilent Technologies Inc. (NYSE: A) will announce its second-quarter fiscal year 2021 financial results on May 25, 2021, after market close. A live webcast of the investor conference call will occur at 1:30 p.m. Pacific time on the same day. The webcast will be available for 90 days on Agilent's website. In fiscal year 2020, Agilent generated revenue of $5.34 billion and has a workforce of 16,400 globally. This event provides investors an insight into the company’s performance and future direction.
Agilent Technologies Inc. (NYSE: A) has achieved the Accountability, Consistency and Transparency (ACT) Label for its InfinityLab LC/MSD iQ and Ultivo Triple Quadrupole LC/MS systems from My Green Lab, enhancing its commitment to sustainability in scientific research.
As part of this initiative, Agilent aims to assist laboratories in reaching their sustainability goals, with 87% of lab managers recognizing its importance. Additionally, Agilent has launched a Plant a Tree program aimed at planting over 1,500 trees across multiple countries by September 2021.
Agilent Technologies, Inc. (NYSE: A) has successfully acquired Resolution Bioscience, enhancing its capabilities in next-generation sequencing (NGS)-based cancer diagnostics. This acquisition expands Agilent's precision oncology solutions, particularly in liquid biopsy-based diagnostics, positioning the company to meet growing market demands. Agilent's CEO, Mike McMullen, emphasized the strategic importance of this addition, which aims to broaden access to NGS-based testing globally. The deal potentially boosts growth in Agilent's diagnostics and genomics sectors.
Agilent Technologies (NYSE: A) awarded Octagon Therapeutics a Golden Ticket during a virtual event on March 24, enabling one scientist's lab bench space for a year at LabCentral. The competition featured three semi-finalists, and Octagon was chosen based on its innovative research approach to autoimmune diseases. Darlene Solomon of Agilent expressed enthusiasm for Octagon's potential, while Isaac Stoner of Octagon highlighted the critical role of Agilent's resources in developing new treatments. Agilent, a leader in life sciences and diagnostics, reported revenue of $5.34 billion in fiscal year 2020.
Agilent Technologies, Inc. (NYSE: A) has declared a quarterly dividend of 19.4 cents per share to be paid on April 28, 2021. This payment will be distributed to shareholders of record as of April 6, 2021. The company generated $5.34 billion in revenue for fiscal year 2020, demonstrating a solid financial backdrop. Future dividend amounts are contingent on the approval from Agilent’s board of directors.
Agilent Technologies (NYSE: A) has launched the Agilent 8697 Headspace Sampler, the first sampler with integrated gas chromatography communication. This innovation enhances instrument intelligence, allowing for improved diagnostics and troubleshooting. Key features include a microchannel-based EPC module for precision, removable sample racks for operational flexibility, and comprehensive connectivity through the GC touch screen. Agilent, a leader in life sciences and diagnostics, generated $5.34 billion in revenue in fiscal 2020.
